application) Eligibility: The research supported by the Pilot and Feasibility Studies Program is primarily intended to be a first grant for junior faculty at the U Washington who have not yet obtained a major peer-reviewed grant (such as an R01 or K21) in the areas of diabetes or endocrinology. Senior faculty members are also eligible to apply if their projects represent first entry into the field of diabetes research. Established investigators in diabetes are also eligible if their purpose is to test innovative ideas that truly represent a clear departure from previous research activity. Any single investigator is eligible to receive a P and F award only once, unless the second P and F is a clear departure from the research area of the original award. Funding level: Since NIH funding to our DERC P and F Studies Program has been $50,000 per year for all P and F projects combined, up to now there has been limited support for each project to a maximum of $25,000 yearly. Awards are made initially for one year, but a second year?s funding is provided if satisfactory progress is made during the first year. Despite these limited funds, there has been a large response to calls for applications and numerous meritorious research projects have been supported. As a result of increased funding to the Diabetes Center for P and F studies, an increase in the funding level and the number of awards in the P and F program is proposed. It is intended that $200,000 of the new DERC budget be allocated to P and F research awards. Recipients must be members of the U. Washington faculty (postdoctoral fellows and research scientists are not eligible) and meet established criteria. The awards will be limited to $50,000 per year for 2 years but some may be smaller. The awards are made on the basis of scientific merit, following rigorous scientific review procedures that have been used in for past applications. New Investigator Awards: The DERC Studies Program also administers the Diabetes Investigator Award Program of $25,000 per year to members of the faculty who are making their first entry into diabetes research. These awards are supported to the private DRTP, an endowed fund of the UW to foster diabetes research. The eligibility and evaluation criteria are the same as the P and F program. Fellowships: The P and F program also administers the McAbee Fellowship Program that is also privately funded by the DRTP.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Center Core Grants (P30)
Project #
2P30DK017047-27
Application #
6612281
Study Section
Special Emphasis Panel (ZDK1-GRB-7 (O1))
Project Start
2002-12-01
Project End
2007-11-30
Budget Start
Budget End
2003-11-30
Support Year
27
Fiscal Year
2003
Total Cost
$303,200
Indirect Cost
Name
University of Washington
Department
Type
DUNS #
605799469
City
Seattle
State
WA
Country
United States
Zip Code
98195
Banks, William A; Kovac, Andrej; Morofuji, Yoichi (2018) Neurovascular unit crosstalk: Pericytes and astrocytes modify cytokine secretion patterns of brain endothelial cells. J Cereb Blood Flow Metab 38:1104-1118
de Groot, Mary; Marrero, David; Mele, Lisa et al. (2018) Depressive Symptoms, Antidepressant Medication Use, and Inflammatory Markers in the Diabetes Prevention Program. Psychosom Med 80:167-173
Roshandel, Delnaz; Gubitosi-Klug, Rose; Bull, Shelley B et al. (2018) Meta-genome-wide association studies identify a locus on chromosome 1 and multiple variants in the MHC region for serum C-peptide in type 1 diabetes. Diabetologia 61:1098-1111
Hannon, Tamara S; Kahn, Steven E; Utzschneider, Kristina M et al. (2018) Review of methods for measuring ?-cell function: Design considerations from the Restoring Insulin Secretion (RISE) Consortium. Diabetes Obes Metab 20:14-24
Brinkley, Tina E; Anderson, Andrea; Soliman, Elsayed Z et al. (2018) Long-Term Effects of an Intensive Lifestyle Intervention on Electrocardiographic Criteria for Left Ventricular Hypertrophy: The Look AHEAD Trial. Am J Hypertens 31:541-548
Kanter, Jenny E; Kramer, Farah; Barnhart, Shelley et al. (2018) A Novel Strategy to Prevent Advanced Atherosclerosis and Lower Blood Glucose in a Mouse Model of Metabolic Syndrome. Diabetes 67:946-959
Redondo, Maria J; Geyer, Susan; Steck, Andrea K et al. (2018) TCF7L2 Genetic Variants Contribute to Phenotypic Heterogeneity of Type 1 Diabetes. Diabetes Care 41:311-317
Guillory, Bobby; Jawanmardi, Nicole; Iakova, Polina et al. (2018) Ghrelin deletion protects against age-associated hepatic steatosis by downregulating the C/EBP?-p300/DGAT1 pathway. Aging Cell 17:
RISE Consortium (2018) Impact of Insulin and Metformin Versus Metformin Alone on ?-Cell Function in Youth With Impaired Glucose Tolerance or Recently Diagnosed Type 2 Diabetes. Diabetes Care 41:1717-1725
Osoti, Alfred; Temu, Tecla M; Kirui, Nicholas et al. (2018) Metabolic Syndrome Among Antiretroviral Therapy-Naive Versus Experienced HIV-Infected Patients Without Preexisting Cardiometabolic Disorders in Western Kenya. AIDS Patient Care STDS 32:215-222

Showing the most recent 10 out of 1296 publications